Ameriprise’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$443M Buy
5,200,321
+2,153,148
+71% +$192M 0.1% 212
2025
Q4
$241M Sell
3,047,173
-3,376,591
-53% -$265M 0.05% 324
2025
Q3
$517M Buy
6,423,764
+314,584
+5% +$26.8M 0.12% 185
2025
Q2
$555M Sell
6,109,180
-867,474
-12% -$79.2M 0.14% 159
2025
Q1
$654M Buy
6,976,654
+177,833
+3% +$15.9M 0.18% 128
2024
Q4
$617M Buy
6,798,821
+246,908
+4% +$23.6M 0.16% 136
2024
Q3
$679M Buy
6,551,913
+171,774
+3% +$17.5M 0.17% 126
2024
Q2
$618M Sell
6,380,139
-207,608
-3% -$19.2M 0.17% 129
2024
Q1
$592M Buy
6,587,747
+3,949,682
+150% +$335M 0.16% 132
2023
Q4
$208M Buy
2,638,065
+760,003
+40% +$57.1M 0.06% 315
2023
Q3
$132M Buy
1,878,062
+385,249
+26% +$28.8M 0.04% 396
2023
Q2
$113M Buy
1,492,813
+149,505
+11% +$11.6M 0.04% 470
2023
Q1
$98.9M Buy
1,343,308
+113,816
+9% +$8.46M 0.03% 491
2022
Q4
$94.7M Buy
1,229,492
+158,466
+15% +$11.9M 0.03% 495
2022
Q3
$74M Buy
1,071,026
+75,990
+8% +$5.96M 0.03% 555
2022
Q2
$77M Sell
995,036
-252,305
-20% -$19.7M 0.03% 572
2022
Q1
$89.4M Sell
1,247,341
-530,248
-30% -$42M 0.03% 565
2021
Q4
$144M Buy
1,777,589
+610,434
+52% +$47.7M 0.04% 449
2021
Q3
$88.2M Sell
1,167,155
-284,304
-20% -$22.6M 0.03% 557
2021
Q2
$118M Sell
1,451,459
-52,300
-3% -$4.28M 0.04% 476
2021
Q1
$119M Sell
1,503,759
-1,318,890
-47% -$103M 0.04% 443
2020
Q4
$241M Sell
2,822,649
-232,085
-8% -$19.2M 0.09% 252
2020
Q3
$236M Sell
3,054,734
-8,449
-0.3% -$644K 0.1% 222
2020
Q2
$224M Sell
3,063,183
-44,704
-1% -$3.18M 0.1% 220
2020
Q1
$206M Buy
3,107,887
+145,085
+5% +$10.2M 0.11% 197
2019
Q4
$204M Sell
2,962,802
-1,451,517
-33% -$99M 0.08% 240
2019
Q3
$324M Buy
4,414,319
+142,543
+3% +$10.3M 0.15% 149
2019
Q2
$306M Buy
4,271,776
+102,085
+2% +$7.25M 0.14% 159
2019
Q1
$286M Buy
4,169,691
+2,760,668
+196% +$178M 0.13% 165
2018
Q4
$83.9M Buy
1,409,023
+104,028
+8% +$6.51M 0.04% 427
2018
Q3
$87.4M Sell
1,304,995
-79,211
-6% -$5.28M 0.03% 512
2018
Q2
$89.7M Buy
1,384,206
+904,227
+188% +$59.1M 0.04% 437
2018
Q1
$34.4M Buy
479,979
+31,404
+7% +$2.26M 0.02% 835
2017
Q4
$33.8M Buy
448,575
+1,887
+0.4% +$138K 0.02% 752
2017
Q3
$32.5M Sell
446,688
-12,856
-3% -$927K 0.02% 741
2017
Q2
$34.1M Sell
459,544
-873,458
-66% -$64.9M 0.02% 703
2017
Q1
$97.6M Buy
1,333,002
+54,898
+4% +$3.84M 0.05% 355
2016
Q4
$83.6M Sell
1,278,104
-545,285
-30% -$37.4M 0.05% 381
2016
Q3
$135M Sell
1,823,389
-58,250
-3% -$4.31M 0.08% 265
2016
Q2
$138M Buy
1,881,639
+1,106,185
+143% +$78.8M 0.08% 246
2016
Q1
$54.8M Sell
775,454
-40,946
-5% -$2.72M 0.03% 451
2015
Q4
$54.4M Buy
816,400
+6,207
+0.8% +$413K 0.03% 448
2015
Q3
$51.4M Buy
810,193
+67,546
+9% +$4.41M 0.03% 471
2015
Q2
$48.6M Buy
742,647
+1,607
+0.2% +$109K 0.03% 536
2015
Q1
$51.4M Buy
741,040
+207,204
+39% +$14.3M 0.03% 519
2014
Q4
$37M Buy
533,836
+29,503
+6% +$1.99M 0.02% 646
2014
Q3
$32.9M Sell
504,333
-2,440,685
-83% -$161M 0.02% 687
2014
Q2
$201M Sell
2,945,018
-1,724,969
-37% -$116M 0.12% 185
2014
Q1
$303M Buy
4,669,987
+482,317
+12% +$30.4M 0.18% 135
2013
Q4
$273M Buy
4,187,670
+873,119
+26% +$55.9M 0.17% 147
2013
Q3
$197M Buy
3,314,551
+36,295
+1% +$2.15M 0.13% 183
2013
Q2
$187M Buy
+3,278,256
New +$195M 0.13% 191

Other funds holding CL

Ameriprise's CL Position: Q1 2026 in Review

Ameriprise increased its Colgate-Palmolive (CL) stake by 71% in Q1 2026, buying an estimated $192M and bringing the position to 5,200,321 shares worth $443M. The position accounts for 0.1% of the portfolio, ranked #212.

Ameriprise first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $679M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Ameriprise held 5,200,321 shares of Colgate-Palmolive worth $443M as of Q1 2026.
  • Ameriprise bought 2,153,148 Colgate-Palmolive shares in Q1 2026, an estimated $192M.
  • Colgate-Palmolive made up 0.1% of Ameriprise's portfolio in Q1 2026, its #212 holding.
  • Ameriprise first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Colgate-Palmolive position peaked at $679M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.